Knight Campus Distinguished Lecture Series
An annual event designed to bring nationally and internationally recognized science, technology and engineering leaders to the University of Oregon community to give their perspective on the future of their fields.
Our Most Recent Speaker
"Engineering of T Cell Cancer Therapies"
Distinguished Lecture Series with David Mooney
Wednesday, Nov. 6, 2024
In his talk, David Mooney discussed how T cell-based therapies are revolutionizing the treatment of some types of cancer, but currently suffer from a number of limitations. To address these challenges, researchers are developing biomaterials capable of concentrating, interrogating, and manipulating stem and immune cells ex vivo and in the body by controlling, in space and time, the interaction of the cells with various immunomodulatory cues. Therapeutic cancer vaccines and the development of artificial antigen presenting cells for the manufacturing and in vivo boosting of adaptive T cell-based therapies will be highlighted.
David Mooney is the Robert Pinkas Family Professor of Bioengineering and a core faculty member in Harvard University's School of Engineering and Applied Sciences and the Wyss Institute for Biologically Inspired Engineering. He is also a member of the Knight Campus External Advisory Board, as well as several national academies, and has won numerous awards for his research and his mentorship/teaching. To learn more about David Mooney, view his bio on the External Advisory Board web page.
The Knight Campus Distinguished Lecture Series is an annual event designed to bring nationally and internationally recognized science, technology and engineering leaders to the University of Oregon community to give their perspective on the future of their fields.
Previous Speakers
Sanjiv Sam Gambhir Professor of Translational Medicine, Professor of Chemical Engineering and, by courtesy of Chemistry of Materials Science and Engineering, and of Operations, Information and Technology at the Graduate School of Business, Stanford University
"The Delicate Interplay Between Light, Interfaces and Design: 3D Printing of Next Generation Controlled Release Systems"
Joseph M. DeSimone discusses Continuous Liquid Interface Production (CLIP) technology, which embodies a convergence of advances in software, hardware, and materials to bring the digital revolution to polymer additive manufacturing..
Assistant Director for Engineering, National Science Foundation (NSF)
"Transforming our World for a Better Tomorrow"
Susan Margulies discusses priorities and opportunities for engineering research and education.
W.T. Doherty-Welch Chair in Chemistry and Distinguished Professor, Texas A&M University
"Synthetic Strategies to Afford Natural Product-Based Polymer Materials: Impacts on Sustainability, Life, Health and the Environment"
Karen Wooley discusses how natural polymer materials can impact sustainability, human health, and the environment.
Director, Knight Cancer Institute
"Imatinib as a Paradigm of Targeted Cancer Therapies"
Brian Druker discussed how he spearheaded the highly successful clinical trials of imatinib for chronic myeloid leukemia, which led to FDA approval of the drug in record time.
CEO and Co-Founder, Chronicle
"Innovation, Leadership, and Change"
Stephen Gillett discussed leadership, transformation, and change and how these elements shaped him into a leader that skirts the norm, strives for innovation, and views change as an opportunity, not a roadblock.